CTX-8371
CTX-8371-001
Phase 1 small_molecule active
Quick answer
CTX-8371 for Non Small Cell Lung Cancer is a Phase 1 program (small_molecule) at Compass Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Compass Therapeutics
- Indication
- Non Small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active